Learn Stocks With Krishna

₹1,062 for ONE share?! 🤯 Is Corona Remedies the next Pharma multibagger or an IPO trap?

The market is buzzing about this IPO (Dec 8-10), but don’t ignore the red flags:
1. Promoters are exiting: 100% OFS structure. 🚩
2. High Valuation: 43x P/E means you’re paying a huge premium for growth.

BUT...
✅ “41% ROCE” (Insane profitability!)
✅ “Fastest growing” in its segment.
✅ “₹300+ GMP” suggesting a solid listing pop.

Should you bet your ₹14,868 on this lot?👇

Check the link in bio for the full “Apply vs. Avoid” breakdown! 🔗

"PhysicsWallah IPO Review 2025" is here! The Edtech giant, known for its affordable learning model, is hitting the market with a ₹3,480 Cr IPO. 🚀

We're diving into the full financial truth:
"Valuation": Is the ₹31,500 Cr post-IPO valuation justified? 🤯
"Financials": Revenue surged to ₹2,887$ Cr in FY25, and Net Losses significantly narrowed to ₹243$ Cr (vs ₹1,131$ Cr loss in FY24). They are now "EBITDA positive!"
"Risks": High competition (Allen, Aakash, Unacademy), reliance on the hybrid (online + offline) model, and the need for sustained profitability.
"The Future": Aggressive expansion into offline centers and new geographies.

Watch till the end for our final verdict: Should you Apply for Listing Gains or is it a Long-Term Bet?

📅 IPO Dates: Nov 11 - Nov 13, 2025

Watch till the end for our final verdict: Subscribe for Long-Term Growth or Skip the Volatility?

📌Subscribe for more insights!
👉OPEN NOW FREE DEMAT ACCOUNT: https://upstox.onelink.me/0H1s/5HAAR7
PS: We are not SEBI registered and this video is only for educational purpose

Drop a comment: Would you apply for the in this IPO?

Pine Labs IPO: The Fintech Titan's Turn! 💥 Is this $3.8K Crore IPO priced for perfection?

We looked at the numbers: "Improved Margins" vs. "Heavy Debt/Valuation". Pine Labs is the backbone of India's merchant payments, but the "11x P/S valuation" is raising eyebrows. 👀

This is a bet on the long-term digitization story, but with a "5% GMP" and a crowded fintech market, are there better opportunities?

Drop a comment: Would you apply for the Pine Labs IPO?

"Groww IPO Review 2025 is LIVE!" 🚀 Should you "APPLY" for one of the most-awaited fintech listings?

We deep dive into Billionbrains Garage Ventures' financials, breaking down their "profitability flip" (from a loss to ₹1,824 Cr profit in FY25!), the premium "valuation ($8 Billion)", and the latest "GMP analysis (up 10-15%)".

Here’s what we cover in 60 seconds:
The Rich Valuation: Is it justified by the growth?
Key Risks: The Big OFS, Competition, and Regulatory Challenges.
The Verdict: Apply for Listing Gains or a Long-Term Hold?
🚨 Watch till the end for my final recommendation: Apply or Avoid?**

"Drop a comment:" Are you applying for the Groww IPO?
📌Subscribe more insights!
PS: We are not SEBI registered, and this video is only for educational purposes.

STOP! Before you open your next demat account, you NEED to see this! 🛑

Zerodha vs Groww in 2025 - The only comparison you need! We break down everything:

💰 Charges: Intraday, Delivery, AMC - Who saves you the most money?

🛡️ Safety: The truth about security and trust.

⚡ Features: Trading tools, mutual funds, and ease of use.

Which broker is taking the crown this year? Watch till the end to find out if you're using the right app! 👇

"Lenskart IPO Review 2025" is here! We dive deep into the Lenskart IPO's "Valuation, Financial Analysis, and GMP" to answer the big question: Should retail investors apply for listing gains or a long-term hold?

Lenskart, one of the biggest consumer tech IPOs of the year, is priced for perfection with a valuation nearing ₹70,000 Cr. We analyze the shift to profitability, the integrated supply chain, and the risks of high valuation and dependence on imports.